11 / 12
Page 34
Notes:
conferenceseries
.com
Volume 4, Issue 4 (Suppl)
J Pharma Care Health Sys
ISSN: 2376-0419, JPCHS, an open access journal
Pharma Middle East 2017
September 25-26, 2017
September 25-26, 2017 Dubai, UAE
12
th
Annual Pharma Middle East Congress
Assessment of disability and medication adherence in patients with rheumatoid arthritis
Mona Alqahtani, Saja Almazrou, Hadir Aljohani and Maram Aljbreen
King Saud University, KSA
Background & Objective:
Rheumatoid Arthritis (RA) patient’s adherence to pharmacologic therapy is important to achieve
therapeutic goals and improve outcomes. Our study objectives are to explore the adherence level, disability index and pain
score in patients with rheumatoid arthritis and to understand the relationship between certain patient variables with adherence
and disability.
Design & Settings:
A cross-sectional study with a self-administered questionnaire to RA patients. Participants gave their
consent and were recruited from outpatient pharmacy waiting areas in different tertiary hospitals in Riyadh, the capital city of
Saudi Arabia.
Patients & Methods:
This study included (126) adults with rheumatoid arthritis. A self-administered questionnaire was given
to RA patients using a special tool that collects demographic and clinical information, adherence and outcome assessment.
Four pages survey that contains three sections: (1) demographic and clinical data, (2) Adherence measured using 8-item
Morisky Medication Adherence Scale (MMAS-8) by using validated Arabic version to assess patient's adherence, and (3)
Health Assessment Questionnaire (HAQ) to assess patient's outcomes.
Results:
Scores of (MMAS-8 items) ranging from 0 to 8 shows that approximately one-half the participants were (n=66)
52.3% are non-adhered or show low adherence while (n=12) 9.5% of patients were adhered (high adherence), the remaining
participants (n=48) shows 38% medium adherence. Those non-adhered, almost (n=23) 18.2% of them shows low adherence
after the first 5 years of diagnosis. About (n=35) 27.7% of none adhered had from 2-3 medications used for RA while those had
more than three medications shows only (n=19) 15% low adherence. There were no significant differences between clinical and
demographic variables between groups.
Conclusion:
The vast majority of RA patients have low to medium adherence score. Advanced age, years of diagnosis and
number of medication significantly affect disability score. However, there is no relationship between these factors and pain
score.
Biography
Mona Alqahtani is a student in College of Pharmacy, King Saud University, Saudi Arabia.
monooosh20@hotmail.comMona Alqahtani et al., J Pharma Care Health Sys 2017, 4:4 (Suppl)
DOI: 10.4172/2376-0419-C1-023